(firstQuint)Evaluation of Safety and Efficacy of DCVAC/LuCa (Immunotherapy of Lung Cancer) in Patients With Metastatic Lung Cancer.

 The purpose of the study is to compare efficacy of DCVAC/LuCa + chemotherapy +/- immune enhancers vs.

 Standard of Care chemotherapy alone in patients with stage IV NSCLC, as measured by progression free survival (PFS).

.

 Evaluation of Safety and Efficacy of DCVAC/LuCa (Immunotherapy of Lung Cancer) in Patients With Metastatic Lung Cancer@highlight

The purpose of the study is to compare efficacy of DCVAC/LuCa + chemotherapy +/- immune enhancers vs.

 chemotherapy alone in patients with stage IV NSCLC, as measured by progression free survival (PFS).

